| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |